AU7906998A - Compounds with growth hormone releasing properties - Google Patents

Compounds with growth hormone releasing properties

Info

Publication number
AU7906998A
AU7906998A AU79069/98A AU7906998A AU7906998A AU 7906998 A AU7906998 A AU 7906998A AU 79069/98 A AU79069/98 A AU 79069/98A AU 7906998 A AU7906998 A AU 7906998A AU 7906998 A AU7906998 A AU 7906998A
Authority
AU
Australia
Prior art keywords
compounds
growth hormone
hormone releasing
releasing properties
properties
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU79069/98A
Inventor
Michael Ankersen
Thomas Kruse Hansen
Nils Langeland Johansen
Jesper Lau
Kjeld Madsen
Bernd Peschke
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Novo Nordisk AS
Original Assignee
Novo Nordisk AS
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novo Nordisk AS filed Critical Novo Nordisk AS
Publication of AU7906998A publication Critical patent/AU7906998A/en
Abandoned legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K7/00Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04Linear peptides containing only normal peptide links
    • C07K7/06Linear peptides containing only normal peptide links having 5 to 11 amino acids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00Drugs for disorders of the endocrine system
    • A61P5/10Drugs for disorders of the endocrine system of the posterior pituitary hormones, e.g. oxytocin, ADH
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K5/00Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/02Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link
    • C07K5/0207Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link containing the structure -NH-(X)4-C(=0), e.g. 'isosters', replacing two amino acids
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K5/00Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/08Tripeptides
    • C07K5/0827Tripeptides containing heteroatoms different from O, S, or N
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biochemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Diabetes (AREA)
  • Endocrinology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
AU79069/98A 1997-06-20 1998-06-12 Compounds with growth hormone releasing properties Abandoned AU7906998A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
DK725/97 1997-06-20
DK72597 1997-06-20
PCT/DK1998/000249 WO1998058950A1 (en) 1997-06-20 1998-06-12 Compounds with growth hormone releasing properties

Publications (1)

Publication Number Publication Date
AU7906998A true AU7906998A (en) 1999-01-04

Family

ID=8096826

Family Applications (1)

Application Number Title Priority Date Filing Date
AU79069/98A Abandoned AU7906998A (en) 1997-06-20 1998-06-12 Compounds with growth hormone releasing properties

Country Status (5)

Country Link
EP (1) EP1005484A1 (en)
JP (1) JP4116097B2 (en)
AU (1) AU7906998A (en)
WO (1) WO1998058950A1 (en)
ZA (1) ZA985278B (en)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE470671T1 (en) * 1998-01-16 2010-06-15 Helsinn Therapeutics Us Inc COMPOUNDS HAVING GROWTH HORMONE RELEASING PROPERTIES
US6083908A (en) * 1998-01-16 2000-07-04 Novo Nordisk A/S Compounds with growth hormone releasing properties
MY153569A (en) 1998-01-20 2015-02-27 Mitsubishi Tanabe Pharma Corp Inhibitors of ?4 mediated cell adhesion
US6919315B1 (en) 1998-06-30 2005-07-19 Novo Nordisk A/S Compounds with growth hormone releasing properties
CA2334315C (en) * 1998-06-30 2011-07-26 Novo Nordisk A/S Compounds with growth hormone releasing properties
EP1930021A3 (en) 1999-02-18 2008-06-18 Kaken Pharmaceutical Co., Ltd. Novel amide derivatives as growth hormone secretagogues
PL366132A1 (en) * 1999-07-26 2005-01-24 Baylor College Of Medicine Super-active porcine growth hormone releasing hormone analog
DE60140285D1 (en) 2000-05-31 2009-12-10 Pfizer Prod Inc Use of growth hormone secretagogues to promote the mobility of the digestive tract
EP1546089A2 (en) 2002-08-09 2005-06-29 TransTech Pharma Inc. Aryl and heteroaryl compounds and methods to modulate coagulation
US7476653B2 (en) 2003-06-18 2009-01-13 Tranzyme Pharma, Inc. Macrocyclic modulators of the ghrelin receptor
US7208601B2 (en) 2003-08-08 2007-04-24 Mjalli Adnan M M Aryl and heteroaryl compounds, compositions, and methods of use
US7501538B2 (en) 2003-08-08 2009-03-10 Transtech Pharma, Inc. Aryl and heteroaryl compounds, compositions and methods of use
CU23558A1 (en) 2006-02-28 2010-07-20 Ct Ingenieria Genetica Biotech COMPOUNDS ANALOG TO THE PEPTIDIC SECRETAGOGS OF THE GROWTH HORMONE
EP2644618B1 (en) 2007-02-09 2016-08-17 Ocera Therapeutics, Inc. tether intermediates for the synthesis of macrocyclic ghrelin receptor modulators
US9119832B2 (en) 2014-02-05 2015-09-01 The Regents Of The University Of California Methods of treating mild brain injury
US20170121385A1 (en) 2015-10-28 2017-05-04 Oxeia Biopharmaceuticals, Inc. Methods of treating neurodegenerative conditions

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1175810A (en) 1979-03-30 1984-10-09 Frank A. Momany Synthetic peptides having pituitary growth hormone releasing activity
AU549053B2 (en) 1981-12-28 1986-01-09 Beckman Instruments, Inc. Synthetic peptides having pituitary growth hormone releasing activity
US4839344A (en) 1987-06-12 1989-06-13 Eastman Kodak Company Polypeptide compounds having growth hormone releasing activity
US4817283A (en) 1987-08-21 1989-04-04 Amp Incorporated Method of forming a modular plug coupler
ATE122357T1 (en) 1988-01-28 1995-05-15 Polygen Holding Corp POLYPEPTIDES WITH A HORMONE-GROWTH-LIBERATING EFFECT.
JPH03504245A (en) 1988-05-11 1991-09-19 ポリゲン ホールディング コーポレイション Polypeptide compounds with growth hormone-releasing activity
IT1240643B (en) 1990-05-11 1993-12-17 Mediolanum Farmaceutici Spa BIOLOGICALLY ACTIVE PEPTIDES CONTAINING IN 2-ALCHYL TRIPTOFANE CHAIN
IL98910A0 (en) 1990-07-24 1992-07-15 Polygen Holding Corp Polypeptide compounds having growth hormone releasing activity and pharmaceutical compositions containing them
US5663146A (en) 1991-08-22 1997-09-02 Administrators Of The Tulane Educational Fund Polypeptide analogues having growth hormone releasing activity
CA2176140A1 (en) 1993-11-24 1995-06-01 Meng Hsin Chen Indolyl group containing compounds and the use thereof to promote the release of growth hormone(s)
CA2179597A1 (en) 1993-12-23 1995-06-29 Nils Langeland Johansen Compounds with growth hormone releasing properties
RU2167881C2 (en) 1993-12-23 2001-05-27 Ново Нордиск А/С Compounds promoting growth hormone release
US5798337A (en) * 1994-11-16 1998-08-25 Genentech, Inc. Low molecular weight peptidomimetic growth hormone secretagogues
MY113488A (en) 1995-01-27 2002-03-30 Novo Nordisk As Compounds with growth hormone releasing properties
PL186520B1 (en) 1995-06-22 2004-01-30 Novo Nordisk As Compunds exhibiting growth hormone liberating properties
DE69637855D1 (en) 1995-12-22 2009-04-16 Novo Nordisk As CONNECTIONS WITH GROWTH HORMONE RELEASING PROPERTIES
DE69734215T2 (en) * 1996-07-22 2006-06-29 Novo Nordisk A/S Compounds with growth hormone-releasing properties

Also Published As

Publication number Publication date
EP1005484A1 (en) 2000-06-07
JP4116097B2 (en) 2008-07-09
JP2002505677A (en) 2002-02-19
ZA985278B (en) 1999-01-19
WO1998058950A1 (en) 1998-12-30

Similar Documents

Publication Publication Date Title
HUP9802580A3 (en) Compounds with growth hormone releasing properties
AU2546399A (en) Preparations with controlled release
HUP9802821A3 (en) Compounds with growth hormone releasing properties
AU2465899A (en) Prostheses with associated growth factors
AU7906998A (en) Compounds with growth hormone releasing properties
AU2382097A (en) Compounds with growth hormone releasing properties
AU4534596A (en) Compounds with growth hormone releasing properties
AU3687297A (en) Insecticidal composition
AU5671099A (en) Compounds having growth hormone releasing activity
AU4534696A (en) Compounds with growth hormone releasing properties
AUPP243898A0 (en) Two-part clip
AU2093997A (en) Spreader
AU2686899A (en) Growth hormone secretagogues
ZA965279B (en) Compounds with growth hormone releasing properties
ZA96544B (en) Compounds with growth hormone releasing properties
ZA9610775B (en) Compounds with growth hormone releasing properties
ZA973483B (en) Compounds with growth hormone releasing properties.
AU5527296A (en) Growth factor htter36
ZA9410262B (en) Compounds with growth hormone releasing properties
AUPP582198A0 (en) Modified human growth hormone
ZA99238B (en) Compounds with growth hormone releasing properties.
ZA200005820B (en) Compounds with growth hormone releasing properties.
AUPO495497A0 (en) Growth factors
AUPO743597A0 (en) Growth factor
AUPP113197A0 (en) Growth factor

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase